The oldest new finding in atopic dermatitis: subclinical miliaria as an origin

Maryam S Haque1, Tesfu Hailu, Ellen Pritchett

  • 1Department of Dermatology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19107, USA.

JAMA Dermatology
|May 30, 2013
PubMed
Abstract

Insights

Blocked sweat ducts, or acrosyringia, are confirmed in atopic dermatitis (AD) patients. This finding suggests subclinical miliaria may initiate AD and its associated itching.

Area of Science:

  • Dermatology
  • Pathology
  • Sweat Gland Biology

Background:

  • A 1947 study by Sulzberger et al. suggested blocked acrosyringia play a key role in atopic dermatitis (AD).
  • Previous research lacked definitive proof due to limitations in available investigative tools.

Purpose of the Study:

  • To histologically confirm the presence of blocked sweat ducts (acrosyringia) in patients diagnosed with atopic dermatitis.
  • To re-evaluate the role of sweat duct obstruction in the pathogenesis of AD.

Main Methods:

  • Biopsy specimens from patients with inflammatory skin diseases, including eczema, were analyzed.
  • Histological examination employed hematoxylin-eosin, periodic acid-Schiff, and Gram staining techniques.
  • Specimens were compared against healthy, non-inflamed skin controls.

Main Results:

  • The study confirmed blocked acrosyringia in all evaluated atopic dermatitis (AD) biopsy specimens using routine hematoxylin-eosin staining.
  • Findings corroborated earlier research on sweat duct blockage in miliaria, identifying periodic acid-Schiff-positive material.
  • Bacteria were observed within the blocked ducts in AD specimens, consistent with findings in miliaria.

Conclusions:

  • Subclinical miliaria, characterized by blocked sweat ducts, may represent an early pathological change in atopic dermatitis (AD).
  • This obstruction is hypothesized to be an initiating factor for the intense pruritus characteristic of AD.